Home LiteratureArticle Details
PMID: 12867595 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3.

Zhang J, Yang J, Roy SK, Tininini S, Hu J, Bromberg JF, Poli V, Stark GR, Kalvakolanu DV

Abstract

GRIM-19 (gene associated with retinoid-IFN-induced mortality 19), isolated as a cell death activator in a genetic screen used to define mechanisms involved in IFN-beta- and retinoic acid-induced cell death, codes for a approximately 16-kDa protein that induces apoptosis in a number of cell lines. Antisense ablation of GRIM-19 caused resistance to cell death induced by IFN plus retinoic acid and conferred a growth advantage to cells. To understand the molecular bases for its cell death regulatory activity, we used a yeast two-hybrid screen and identified that the transcription factor STAT3 (signal transducer and activator of transcription 3) binds to GRIM-19. GRIM-19 inhibits transcription driven by activation of STAT3, but not STAT1. It neither inhibits the ligand-induced activation of STAT3 nor blocks its ability to bind to DNA. Mutational analysis indicates that the transactivation domain of STAT3, especially residue S727, is required for GRIM-19 binding. Because GRIM-19 does not bind significantly to other STATs, our studies identify a specific inhibitor of STAT3. Because constitutively active STAT3 up-regulates antiapoptotic genes to promote tumor survival, its inhibition by GRIM-19 also demonstrates an antioncogenic effect exerted by biological therapeutics.

MeSH Terms
Animals Apoptosis Apoptosis Regulatory Proteins Cell Death DNA/metabolism DNA Mutational Analysis DNA-Binding Proteins/antagonists & inhibitors,metabolism,physiology Humans Interferon-beta/pharmacology Ligands Mice NADH, NADPH Oxidoreductases/physiology Oligonucleotide Array Sequence Analysis Oligonucleotides, Antisense/pharmacology Plasmids/metabolism Protein Binding Protein Structure, Tertiary STAT1 Transcription Factor STAT3 Transcription Factor Serine/chemistry Trans-Activators/antagonists & inhibitors,metabolism,physiology Transfection Tretinoin/pharmacology Two-Hybrid System Techniques Up-Regulation
Chemicals
Apoptosis Regulatory Proteins DNA-Binding Proteins Ligands Oligonucleotides, Antisense STAT1 Transcription Factor STAT1 protein, human STAT3 Transcription Factor STAT3 protein, human Stat1 protein, mouse Stat3 protein, mouse Trans-Activators Serine Tretinoin Interferon-beta DNA NADH, NADPH Oxidoreductases Grim19 protein, mouse NDUFA13 protein, human
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Zhang Jun
Greenebaum Cancer Center, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Yang Jinbo
Roy Sanjit K
Tininini Silvia
Hu Jiadi
Bromberg Jacqueline F
Poli Valeria
Stark George R
Kalvakolanu Dhananjaya V
References (48)
48 references, click to expand
  1. Interferons and cell growth control.
    Histol Histopathol. 2000 Apr;15(2):523-37 PMID: 10809374
  2. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein.
    Science. 1995 Jul 7;269(5220):81-3 PMID: 7541555
  3. Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approach.
    J Biol Chem. 2000 Oct 27;275(43):33416-26 PMID: 10924506
  4. Protein inhibitor of activated STAT3 regulates androgen receptor signaling in prostate carcinoma cells.
    Biochem Biophys Res Commun. 2000 Nov 11;278(1):9-13 PMID: 11071847
  5. Regulation of Bcl-xL: a little bit of this and a little bit of STAT.
    Curr Opin Oncol. 2000 Nov;12(6):543-9 PMID: 11085453
  6. ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation.
    Mol Endocrinol. 2000 Dec;14(12):1986-2000 PMID: 11117529
  7. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway.
    Cell. 1996 Feb 9;84(3):431-42 PMID: 8608597
  8. Double-stranded RNA-dependent protein kinase mediates c-Myc suppression induced by type I interferons.
    J Biol Chem. 1996 Oct 11;271(41):25479-84 PMID: 8810318
  9. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene.
    Cell. 1996 Oct 18;87(2):307-17 PMID: 8861914
  10. Inhibition of E2F-mediated transcription by p202.
    EMBO J. 1996 Oct 15;15(20):5668-78 PMID: 8896460
  11. Transcriptional activation of the cdc2 gene is associated with Fas-induced apoptosis of human hematopoietic cells.
    J Biol Chem. 1996 Nov 8;271(45):28469-77 PMID: 8910474
  12. Increasing effectiveness of interferon-alpha for malignancies.
    Semin Oncol. 1997 Jun;24(3 Suppl 9):S9-99-S9-104 PMID: 9208879
  13. The interferon-inducible murine p48 (ISGF3gamma) gene is regulated by protooncogene c-myc.
    Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7227-32 PMID: 9207073
  14. Cyclin-dependent kinase activation and S-phase induction of the cyclin B1 gene are linked through the CCAAT elements.
    Cell Growth Differ. 1997 Jul;8(7):811-20 PMID: 9218875
  15. Specific inhibition of Stat3 signal transduction by PIAS3.
    Science. 1997 Dec 5;278(5344):1803-5 PMID: 9388184
  16. Stat3 activation is required for cellular transformation by v-src.
    Mol Cell Biol. 1998 May;18(5):2553-8 PMID: 9566875
  17. DAP genes: novel apoptotic genes isolated by a functional approach to gene cloning.
    Biochim Biophys Acta. 1998 Apr 17;1377(2):F13-33 PMID: 9606974
  18. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.
    Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7556-61 PMID: 9636188
  19. Thioredoxin reductase mediates cell death effects of the combination of beta interferon and retinoic acid.
    Mol Cell Biol. 1998 Nov;18(11):6493-504 PMID: 9774665
  20. Growth inhibition of cultured human Tenon's fibroblastic cells by targeting the E2F transcription factor.
    Exp Eye Res. 1998 Oct;67(4):395-401 PMID: 9820786
  21. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
    Clin Cancer Res. 1997 Jun;3(6):931-7 PMID: 9815768
  22. Negative regulation of the JAK/STAT pathway.
    Bioessays. 1999 Jan;21(1):47-52 PMID: 10070253
  23. Systemic interferon-alpha (IFN-alpha) treatment leads to Stat3 inactivation in melanoma precursor lesions.
    Mol Med. 1999 Jan;5(1):11-20 PMID: 10072444
  24. The interferon-inducible nucleolar p204 protein binds the ribosomal RNA-specific UBF1 transcription factor and inhibits ribosomal RNA transcription.
    EMBO J. 1999 May 17;18(10):2845-54 PMID: 10329630
  25. Stat3 as an oncogene.
    Cell. 1999 Aug 6;98(3):295-303 PMID: 10458605
  26. p130/E2F4 binds to and represses the cdc2 promoter in response to p53.
    J Biol Chem. 2001 Jan 19;276(3):1998-2006 PMID: 11032828
  27. Antiviral response in cells containing Stat1 with heterologous transactivation domains.
    J Virol. 2001 Mar;75(6):2627-33 PMID: 11222685
  28. GRIM-19, a cell death regulatory gene product, is a subunit of bovine mitochondrial NADH:ubiquinone oxidoreductase (complex I).
    J Biol Chem. 2001 Oct 19;276(42):38345-8 PMID: 11522775
  29. A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases.
    Genes Dev. 2001 Dec 1;15(23):3053-8 PMID: 11731472
  30. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.
    Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2872-7 PMID: 11867732
  31. The roles of IFN gamma in protection against tumor development and cancer immunoediting.
    Cytokine Growth Factor Rev. 2002 Apr;13(2):95-109 PMID: 11900986
  32. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.
    Clin Cancer Res. 2002 Apr;8(4):945-54 PMID: 11948098
  33. Identification of the p33(ING1)-regulated genes that include cyclin B1 and proto-oncogene DEK by using cDNA microarray in a mouse mammary epithelial cell line NMuMG.
    Cancer Res. 2002 Apr 15;62(8):2203-9 PMID: 11956069
  34. Stat proteins and oncogenesis.
    J Clin Invest. 2002 May;109(9):1139-42 PMID: 11994401
  35. Mutational switch of an IL-6 response to an interferon-gamma-like response.
    Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8043-7 PMID: 12060750
  36. Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death.
    J Virol. 2002 Sep;76(17):8797-807 PMID: 12163600
  37. Stats: transcriptional control and biological impact.
    Nat Rev Mol Cell Biol. 2002 Sep;3(9):651-62 PMID: 12209125
  38. Characterization of monoclonal antibodies against GRIM-19, a novel IFN-beta and retinoic acid-activated regulator of cell death.
    J Interferon Cytokine Res. 2002 Oct;22(10):1017-26 PMID: 12433281
  39. GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction.
    EMBO J. 2003 Mar 17;22(6):1325-35 PMID: 12628925
  40. A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal.
    Science. 1991 Apr 5;252(5002):117-20 PMID: 1901424
  41. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia.
    Science. 1993 Feb 12;259(5097):968-71 PMID: 8438156
  42. Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells.
    Mol Cell Biol. 1993 Sep;13(9):5255-65 PMID: 7689148
  43. Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways.
    EMBO J. 1993 Nov;12(11):4221-8 PMID: 7693454
  44. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6.
    Science. 1994 Apr 1;264(5155):95-8 PMID: 8140422
  45. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway.
    Cell. 1994 Apr 8;77(1):63-71 PMID: 7512451
  46. Evidence for post-transcriptional regulation of cyclin B1 mRNA in the cell cycle and following irradiation in HeLa cells.
    EMBO J. 1995 Feb 1;14(3):603-9 PMID: 7859748
  47. Requirement of serine phosphorylation for formation of STAT-promoter complexes.
    Science. 1995 Mar 31;267(5206):1990-4 PMID: 7701321
  48. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Oncogene. 2000 Sep 28;19(41):4795-801 PMID: 11032030
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2003-08-05
Epub
2003-00-16
Pages
9342-7
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC170920
Subset
IM
Grants
NCI NIH HHS · R01 CA078282 · United States
NCI NIH HHS · CA71401 · United States
NCI NIH HHS · CA78282 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com